|Bid||503.60 x 800|
|Ask||506.74 x 3100|
|Day's Range||503.81 - 515.94|
|52 Week Range||328.13 - 664.64|
|Beta (5Y Monthly)||0.40|
|PE Ratio (TTM)||18.51|
|Earnings Date||Feb 04, 2021 - Feb 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||673.13|
Scott+Scott Continues Investigation of Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty – REGN
The Interfaith Center on Corporate Responsibility has filed shareholder proposals at six pharmaceutical companies.
This coming weekend, doctors who treat blood disorders will convene virtually to discuss new treatments that are extending the lives of patients.